Corrigendum to "Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth" [Steroids 129 (2018) 24-34]
Steroids
.
2018 Aug:136:93.
doi: 10.1016/j.steroids.2018.06.001.
Authors
Vladimir A Zolottsev
1
,
Yaroslav V Tkachev
2
,
Alexandra S Latysheva
1
,
Vladimir A Kostin
1
,
Roman A Novikov
2
,
Vladimir P Timofeev
2
,
Galina E Morozevich
1
,
Alexey V Kuzikov
1
,
Victoria V Shumyantseva
1
,
Alexander Y Misharin
1
Affiliations
1
Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
2
Engelhardt Institute of Molecular Biology RAS, Moscow, Russia.
PMID:
29880207
DOI:
10.1016/j.steroids.2018.06.001
No abstract available
Publication types
Published Erratum